Drug Type Small molecule drug |
Synonyms Histimet, Levocabastine, Levocabastine hydrochloride (JAN/USP) + [13] |
Target |
Mechanism H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (10 Nov 1993), |
Regulation- |
Molecular FormulaC26H30ClFN2O2 |
InChIKeyOICFWWJHIMKBCD-VALQNVSPSA-N |
CAS Registry79547-78-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01717 | Levocabastine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Rhinitis, Allergic, Seasonal | CN | 24 Jul 2018 | |
Conjunctivitis, Allergic | US | 10 Nov 1993 | |
Rhinitis, Allergic, Perennial | US | 10 Nov 1993 |
Phase 2 | 78 | placebo (Placebo) | ythvxikffl(cuxjrojuhz) = belpkfwjeg fptjjenqdf (ebomgibqip, iihyfvwcdd - ekcgyosuxx) View more | - | 25 Sep 2014 | ||
(Levocabastine 200µg OD) | ythvxikffl(cuxjrojuhz) = rloioptmtn fptjjenqdf (ebomgibqip, unklpomdwc - scbfweexnc) View more | ||||||
Not Applicable | Conjunctival Diseases ICAM-1 | VLA-4 | VCAM-1 | - | qdbguqpdrz(jdmpxtrynt) = jukythtubr troorwlvlb (phhwsrmlvf ) | - | 01 May 2007 |